Analysts rate Singapore's Raffles Medical "buy" on new partnership

King International Investment

02/06/2021 09:58

** Shares of integrated healthcare provider Raffles Medical
Group Ltd  RAFG.SI  unchanged at S$1.15 at 0845 GMT, lowest
since April
** YTD, Raffles Medical Group Ltd up 14.6%
** Raffles Medical Group and China Life Healthcare Investment
Company enter strategic partnership on provision of medical
services, healthcare management  urn:newsml:reuters.com:*:nFWN2NJ0HS
** 9 analysts cover Raffles Medical Group Ltd, on avg rating it
"BUY". Its median PT is S$1.11, which is 2.7% above its current
price of S$1.1 - Refinitiv data
** The stock is 3.4% below its 52-week high reached April 6

 (Reporting by Chen Lin in Singapore)
 ((LinChen1@tr.com))